Literature DB >> 24425596

Response: galactose treatment in focal segmental glomerulosclerosis.

Asha Moudgil1, Kristen Sgambat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24425596     DOI： 10.1007/s00467-013-2701-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  3 in total

1.  Partial remission of resistant nephrotic syndrome after oral galactose therapy.

Authors:  Matjaž Kopač; Anamarija Meglič; Rina R Rus
Journal:  Ther Apher Dial       Date:  2011-06       Impact factor: 1.762

2.  Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome.

Authors:  Kristen Sgambat; Mindy Banks; Asha Moudgil
Journal:  Pediatr Nephrol       Date:  2013-06-22       Impact factor: 3.714

3.  FSGS permeability factor-associated nephrotic syndrome: remission after oral galactose therapy.

Authors:  Eric De Smet; Jean-Philippe Rioux; Hélène Ammann; Clément Déziel; Serge Quérin
Journal:  Nephrol Dial Transplant       Date:  2009-06-09       Impact factor: 5.992
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.